Changes in Pulse Wave Transit Time and Its Variability After Placement of Interscalene Brachial Plexus Block

January 22, 2024 updated by: JongHae Kim

Changes in Pulse Wave Transit Time and Its Variability Measured From the Ipsilateral First Finger After Placement of Interscalene Brachial Plexus Block

Pulse wave transit time (PWTT) increases due to decreased arterial vascular tone resulting from sympathetic blockade caused by regional anesthesia. Its oscillation (PWTT variability) also contains information on the interaction between autonomic nervous system and the cardiovascular system. The changes in PWTT and its variability have not been investigated in patients receiving interscalene brachial plexus block (ISBPB). It was hypothesized that ISBPB increases PWTT and reduces low frequency power of PWTT variability.

Study Overview

Status

Completed

Study Type

Observational

Enrollment (Actual)

59

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Daegu, Korea, Republic of, 42472
        • Daegu Catholic University Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Tertiary university medical center

Description

Inclusion Criteria:

  • American Society of Anesthesiologists status of 1
  • Scheduled to receive interscalene brachial plexus block for arthroscopic shoulder surgery

Exclusion Criteria:

  • Coagulopathy
  • Infection of the skin area for interscalene brachial plexus block
  • Peripheral neuropathy or neurologic sequelae in the upper limb ipsilateral to the surgery
  • Allergy to local anesthetics or a history of allergic shock
  • Contralateral vocal cord palsy, hemidiaphragmatic paresis/paralysis or pneumo/hemo thorax
  • Arrhythmias
  • Cardiac conduction abnormalities
  • A history of medication affecting cardiac conduction
  • Ischemic heart disease
  • Hypertension
  • Diabetes mellitus
  • Thyroid disfunction
  • Other medical conditions affecting autonomic nervous activity

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
ISBPB group
Interscalene brachial plexus block involving the C5 to C8 nerve roots
Using a linear ultrasound transducer connected to an ultrasound machine, the compactly arranged brachial plexus is visualized lateral to the pulsating subclavian artery. The transducer is moved cephalad to visualize the 5th to 8th cervical (C5 to C8) nerve roots located between the anterior and middle scalene muscles. Using an in-plane technique, a block needle is inserted close to a nerve root in a lateral-to-medial direction. The needle is moved to place 0.75% ropivacaine around each nerve root. The C8 nerve root is blocked first, and the C5 nerve root is blocked last. After blocking the four cervical nerve roots, ropivacaine is placed in the intermuscular plane between the sternocleidomastoid and scalene muscles to block the supraclavicular nerves. A total of 26 ml of 0.75% ropivacaine is used for the interscalene brachial plexus block (6 ml per nerve root and 2 ml for the supraclavicular nerves).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Natural-log-transformed low frequency power of pulse wave transit time variability
Time Frame: Between 15 and 20 minutes after block needle insertion
Calculated by integrating the power spectra of pulse wave transit time variability between 0.04 and 0.15 Hz.
Between 15 and 20 minutes after block needle insertion

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Natural-log-transformed low frequency power of pulse wave transit time variability
Time Frame: During 5 minutes before the end of the acclimatization period
Calculated by integrating the power spectra of pulse wave transit time variability between 0.04 and 0.15 Hz.
During 5 minutes before the end of the acclimatization period
Natural-log-transformed low frequency power of pulse wave transit time variability
Time Frame: Between 5 and 10 minutes after block needle insertion
Calculated by integrating the power spectra of pulse wave transit time variability between 0.04 and 0.15 Hz.
Between 5 and 10 minutes after block needle insertion
Natural-log-transformed high frequency power of pulse wave transit time variability
Time Frame: During 5 minutes before the end of the acclimatization period
Calculated by integrating the power spectra of pulse wave transit time variability between 0.15 and 0.4 Hz.
During 5 minutes before the end of the acclimatization period
Natural-log-transformed high frequency power of pulse wave transit time variability
Time Frame: Between 5 and 10 minutes after block needle insertion
Calculated by integrating the power spectra of pulse wave transit time variability between 0.15 and 0.4 Hz.
Between 5 and 10 minutes after block needle insertion
Natural-log-transformed high frequency power of pulse wave transit time variability
Time Frame: Between 15 and 20 minutes after block needle insertion
Calculated by integrating the power spectra of pulse wave transit time variability between 0.15 and 0.4 Hz.
Between 15 and 20 minutes after block needle insertion
Pulse wave transit time
Time Frame: During 5 minutes before the end of the acclimatization period
Time difference in milliseconds between the R peak of the electrocardiographic waveform and the peak of the 2nd-derivative photoplethysmographic waveform.
During 5 minutes before the end of the acclimatization period
Pulse wave transit time
Time Frame: Between 5 and 10 minutes after block needle insertion
Time difference in milliseconds between the R peak of the electrocardiographic waveform and the peak of the 2nd-derivative photoplethysmographic waveform.
Between 5 and 10 minutes after block needle insertion
Pulse wave transit time
Time Frame: Between 15 and 20 minutes after block needle insertion
Time difference in milliseconds between the R peak of the electrocardiographic waveform and the peak of the 2nd-derivative photoplethysmographic waveform.
Between 15 and 20 minutes after block needle insertion
Sensory blockade
Time Frame: 20 minutes after block needle insertion
Assessed by grading the coldness with a 3-level scale consisting of 0 (no cold sensation), 1 (reduced cold sensation), and 2 (normal cold sensation) after applying an alcohol swab to the upper limb dermatomal areas innervated by the C5 to T1 nerve roots.
20 minutes after block needle insertion
Motor blockade
Time Frame: 20 minutes after block needle insertion
The muscle contraction power is rated as 0 (complete block), 1 (partial block), and 2 (no block) for shoulder abduction (axillary nerve), elbow flexion (musculocutaneous nerve), forearm supination (radial nerve), forearm pronation (median nerve), wrist extension (radial nerve), wrist flexion (median nerve), finger abduction (ulnar nerve), thumb abduction (radial nerve), thumb adduction (ulnar nerve), and thumb opposition (median nerve).
20 minutes after block needle insertion
Bilateral pupil diameters
Time Frame: Within 1 minute after acclimatization
Measured using a portable automated monocular infrared pupillometer (PLR-3000, NeurOptics Inc., Irvine, CA, the United States) at 30 Hz for 2 seconds.
Within 1 minute after acclimatization
Bilateral pupil diameters
Time Frame: 20 minutes after block needle insertion
Measured using a portable automated monocular infrared pupillometer (PLR-3000, NeurOptics Inc., Irvine, CA, the United States) at 30 Hz for 2 seconds.
20 minutes after block needle insertion
Incidence of side effects related to interscalene brachial plexus block
Time Frame: 20 minutes after block needle insertion
Horner's syndrome, subjective dyspnea, and hoarseness
20 minutes after block needle insertion

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Jonghae Kim, M.D., Daegu Catholic University Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 31, 2023

Primary Completion (Actual)

January 7, 2024

Study Completion (Actual)

January 7, 2024

Study Registration Dates

First Submitted

June 28, 2023

First Submitted That Met QC Criteria

July 11, 2023

First Posted (Actual)

July 13, 2023

Study Record Updates

Last Update Posted (Estimated)

January 23, 2024

Last Update Submitted That Met QC Criteria

January 22, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 2023-01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

IPD will be available from the primary investigator on reasonable request.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Interscalene Brachial Plexus Block

Clinical Trials on Interscalene brachial plexus block

Subscribe